Veracyte Non-GAAP EPS of $0.53 beats by $0.12, revenue of $140.6M beats by $4.81M
Source: SeekingAlpha
2026-02-25 16:52:32 ET
More on Veracyte
- Veracyte: Profitable, De-Risked, And Ready To Run
- Veracyte, Inc. (VCYT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Veracyte, Inc. (VCYT) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Veracyte reports Q4 preliminary revenue in the range of $138M - $140M
- Seeking Alpha’s Quant Rating on Veracyte
Read the full article on Seeking Alpha
For further details see:
Veracyte Non-GAAP EPS of $0.53 beats by $0.12, revenue of $140.6M beats by $4.81M
Veracyte Inc.
NASDAQ: VCYT
VCYT Trading
-2.6% G/L:
$32.47 Last:
171,614 Volume:
$32.80 Open:
VCYT Latest News
February 25, 2026 04:05:00 pm
Veracyte Announces Fourth Quarter and Full Year 2025 Financial Results
VCYT Stock Data
$2,908,219,075
77,942,485
0.94%
127
N/A
Medical Diagnostics & Screening
Healthcare
US
South San Francisco
